PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 96 filers reported holding PHATHOM PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $127,033 | -14.8% | 12,250 | +17.6% | 0.00% | – |
| Q2 2023 | $149,157 | +33.6% | 10,416 | +3.3% | 0.00% | – |
| Q3 2022 | $111,686 | +26.2% | 10,080 | -3.9% | 0.00% | – |
| Q2 2022 | $88,485 | -60.7% | 10,484 | -8.4% | 0.00% | – |
| Q4 2021 | $225,000 | -37.3% | 11,443 | +2.3% | 0.00% | – |
| Q3 2021 | $359,000 | -10.7% | 11,190 | -5.9% | 0.00% | – |
| Q2 2021 | $402,000 | +50.0% | 11,889 | +66.9% | 0.00% | – |
| Q1 2021 | $268,000 | +17.5% | 7,124 | +3.9% | 0.00% | – |
| Q4 2020 | $228,000 | -7.7% | 6,857 | +1.7% | 0.00% | – |
| Q3 2020 | $247,000 | +8.8% | 6,744 | 0.0% | 0.00% | – |
| Q2 2020 | $227,000 | – | 6,744 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 2,484,274 | $27,873,554 | 11.71% |
| Frazier Life Sciences Management, L.P. | 8,407,152 | $94,328,245 | 5.86% |
| Abingworth LLP | 1,435,106 | $16,101,889 | 5.25% |
| Opaleye Management Inc. | 417,500 | $4,684,350 | 1.63% |
| 683 Capital Management, LLC | 1,350,000 | $15,147,000 | 1.28% |
| Newtyn Management, LLC | 484,074 | $5,431,310 | 1.12% |
| Penn Mutual Asset Management | 62,802 | $704,638 | 0.79% |
| StepStone Group LP | 422,085 | $4,735,794 | 0.62% |
| MPM BioImpact LLC | 195,942 | $2,198,469 | 0.57% |
| Avidity Partners Management LP | 1,900,000 | $21,318,000 | 0.46% |